37 related articles for article (PubMed ID: 25816405)
1. Knockdown of PTTG1 inhibits the growth and invasion of lung adenocarcinoma cells through regulation of TGFB1/SMAD3 signaling.
Li WH; Chang L; Xia YX; Wang L; Liu YY; Wang YH; Jiang Z; Xiao J; Wang ZR
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):45-52. PubMed ID: 25816405
[TBL] [Abstract][Full Text] [Related]
2. Pituitary tumor transforming gene 1 promotes proliferation and malignant phenotype in osteosarcoma via NF-κB signaling.
Hu X; Yang F; Mei H
J Orthop Sci; 2024 Jan; 29(1):306-314. PubMed ID: 36414514
[TBL] [Abstract][Full Text] [Related]
3. SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma.
Teveroni E; Di Nicuolo F; Vergani E; Oliva A; Vodola EP; Bianchetti G; Maulucci G; De Spirito M; Cenci T; Pierconti F; Gulino G; Iavarone F; Urbani A; Milardi D; Pontecorvi A; Mancini F
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069214
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-regulated PTTG1 promotes breast cancer progression by regulating cyclin kinase expression.
Meng C; Zou Y; Hong W; Bao C; Jia X
Mol Med; 2020 Apr; 26(1):33. PubMed ID: 32272902
[TBL] [Abstract][Full Text] [Related]
5. POH1 induces Smad3 deubiquitination and promotes lung cancer metastasis.
Yuan Y; Li Y; Wu X; Bo J; Zhang L; Zhang J; Hu Y; Chen Y; Zeng Y; Wei X; Zhang H
Cancer Lett; 2024 Feb; 582():216526. PubMed ID: 38061486
[TBL] [Abstract][Full Text] [Related]
6. Network analysis of DEGs and verification experiments reveal the notable roles of PTTG1 and MMP9 in lung cancer.
Xu X; Cao L; Zhang Y; Yin Y; Hu X; Cui Y
Oncol Lett; 2018 Jan; 15(1):257-263. PubMed ID: 29387220
[TBL] [Abstract][Full Text] [Related]
7. IFIH1-mediated post-transcriptional regulation of PTTG1 promotes proliferation and affects PHA-848125 sensitivity and prognosis in oropharyngeal carcinoma.
Li X; Ding N; Ma W; Zhang M
Am J Cancer Res; 2024; 14(5):2157-2171. PubMed ID: 38859832
[TBL] [Abstract][Full Text] [Related]
8. FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasion.
Zheng Y; Guo J; Zhou J; Lu J; Chen Q; Zhang C; Qing C; Koeffler HP; Tong Y
BMC Med Genomics; 2015 Aug; 8():49. PubMed ID: 26264222
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance and potential regulatory mechanism of overexpression of pituitary tumor-transforming gene transcription factor in bladder cancer.
Li JD; Farah AA; Huang ZG; Zhai GQ; Wang RG; Liu JL; Wang QJ; Zhang GL; Lei ZL; Dang YW; Li SH
BMC Cancer; 2022 Jun; 22(1):713. PubMed ID: 35768832
[TBL] [Abstract][Full Text] [Related]
10. Upregulated expression of
He Y; Du Z; Peng H; Reddy AV; Cao P
J Gastrointest Oncol; 2024 Feb; 15(1):435-457. PubMed ID: 38482253
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of single-cell and bulk RNA-sequencing data revealed T cell marker genes based molecular sub-types and a prognostic signature in lung adenocarcinoma.
Peng Y; Dong Y; Sun Q; Zhang Y; Zhou X; Li X; Ma Y; Liu X; Li R; Guo F; Guo L
Sci Rep; 2024 Jan; 14(1):964. PubMed ID: 38200058
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of PTTG1 and Its Methylation in Lung Adenocarcinoma.
Bai L; Li LH; Liang J; Li EX
J Oncol; 2022; 2022():3507436. PubMed ID: 35251171
[TBL] [Abstract][Full Text] [Related]
13. Identification of 5-Gene Signature Improves Lung Adenocarcinoma Prognostic Stratification Based on Differential Expression Invasion Genes of Molecular Subtypes.
Zheng Z; Deng W; Yang J
Biomed Res Int; 2020; 2020():8832739. PubMed ID: 33490259
[TBL] [Abstract][Full Text] [Related]
14. Analysis and Identification of Tumorigenic Targets of MicroRNA in Cancer Cells by Photoreactive Chemical Probes.
Su Z; Ganbold T; Baigude H
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102467
[TBL] [Abstract][Full Text] [Related]
15. Distinct expression pattern and prognostic values of pituitary tumor transforming gene family genes in non-small cell lung cancer.
Yang S; Wang X; Liu J; Ding B; Shi K; Chen J; Lou W
Oncol Lett; 2019 Nov; 18(5):4481-4494. PubMed ID: 31611957
[TBL] [Abstract][Full Text] [Related]
16. Integrated Analysis of Transcriptome and Prognosis Data Identifies FGF22 as a Prognostic Marker of Lung Adenocarcinoma.
Liu HY; Zhao H; Li WX
Technol Cancer Res Treat; 2019 Jan; 18():1533033819827317. PubMed ID: 30803369
[TBL] [Abstract][Full Text] [Related]
17. Aberrant CpG-methylation affects genes expression predicting survival in lung adenocarcinoma.
He W; Ju D; Jie Z; Zhang A; Xing X; Yang Q
Cancer Med; 2018 Nov; 7(11):5716-5726. PubMed ID: 30353687
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA CCAT2 is activated by E2F1 and exerts oncogenic properties by interacting with PTTG1 in pituitary adenomas.
Fu D; Zhang Y; Cui H
Am J Cancer Res; 2018; 8(2):245-255. PubMed ID: 29511595
[TBL] [Abstract][Full Text] [Related]
19. Targeting the
Caporali S; Alvino E; Lacal PM; Ruffini F; Levati L; Bonmassar L; Scoppola A; Marchetti P; Mastroeni S; Antonini Cappellini GC; D'Atri S
Oncotarget; 2017 Dec; 8(69):113472-113493. PubMed ID: 29371923
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of securin expression and sub-cellular localization in human breast cancer.
Gurvits N; Repo H; Löyttyniemi E; Nykänen M; Anttinen J; Kuopio T; Talvinen K; Kronqvist P
Cell Oncol (Dordr); 2016 Aug; 39(4):319-31. PubMed ID: 26984614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
